The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dobrokhotova Iu.É.

Kafedra akusherstva i ginekologii Moskovskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Borovkova E.I.

Kafedra akusherstva i ginekologii fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Bondarenko K.R.

Department of Obstetrics and Gynecology, Faculty of General Medicine, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia

Vulvovaginal candidiasis: The state of knowledge of the problem

Authors:

Dobrokhotova Iu.É., Borovkova E.I., Bondarenko K.R.

More about the authors

Read: 37576 times


To cite this article:

Dobrokhotova IuÉ, Borovkova EI, Bondarenko KR. Vulvovaginal candidiasis: The state of knowledge of the problem. Russian Bulletin of Obstetrician-Gynecologist. 2017;17(3):108‑111. (In Russ.)
https://doi.org/10.17116/rosakush2017173108-111

Recommended articles:
Unre­solved problem: Chemotherapy-Induced Peri­pheral Neuropathy. P.A. Herzen Journal of Onco­logy. 2024;(5):76-81
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84

References:

  1. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1.
  2. Bydanov PV. Modern approaches to treatment and prevention of genital candidiasis. Ginekologiya. 2007;9:2:12-17. (In Russ.).
  3. Tibaldi C, Cappello N, Latino MA. Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect. 2009;15:670. doi:10.1111/j.1469-0691.2009.02842.x
  4. Foxman B, Muraglia R, Dietz JP. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17:340. doi:10.1097/LGT.0b013e318273e8cf
  5. Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961. doi:10.1016/S0140-6736(07)60917-9
  6. Vermitsky JP, Self MJ, Chadwick SG. Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol. 2008;46:1501. doi:10.1128/JCM.02485-07
  7. McClelland RS, Richardson BA, Hassan WM. Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis. J Infect Dis. 2009;199:1883. doi:10.1086/599213.8
  8. Sergeev AYu, Sergeev YuV. [Candidiasis. The nature of the infection, the mechanisms of aggression and defense, laboratory diagnosis, clinic and treatment]. Moscow: Triada-X. 2001;472.
  9. Vitali B, Pugliese C, Biagi E. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol. 2007;73:5731. doi:10.1128/AEM.01251-07
  10. Zhou X, Westman R, Hickey R. Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun. 2009;77:4130. doi:10.1128/IAI.00436-09
  11. Liu F, Liao Q, Liu Z. Mannose-binding lectin and vulvovaginal candidiasis. Int J Gynaecol Obstet. 2006;92:43. doi:10.1016/j.ijgo.2005.08.024
  12. Donders GG, Babula O, Bellen G. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG. 2008;115:1225. doi:10.1111/j.1471-0528.2008.01830.x
  13. Babula O, Lazdāne G, Kroica J. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis. 2005;40:1258. doi:10.1086/429246
  14. Ray D, Goswami R, Banerjee U. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care. 2007;30:312. doi:10.2337/dc06-1469
  15. Patel DA, Gillespie B, Sobel JD. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol. 2004;190:644. doi:10.1016/j.ajog.2003.11.027
  16. Heng LS, Yatsuya H, Morita S, Sakamoto J. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis. J Epidemiol. 2010;20:70. PMID: 20009371. PMCID: PMC3900782
  17. Janković S, Bojović D, Vukadinović D. Risk factors for recurrent vulvovaginal candidiasis. Vojnosanit Pregl. 2010;67:819.
  18. Mendling W, Brasch J. German Society for Gynecology and Obstetrics. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mycoses. 2012;55:Suppl 3:1. doi:10.1111/j.1439-0507.2012.02185.x
  19. Diba K, Namaki A, Ayatolahi H, Hanifian H. Rapid identification of drug resistant Candida species causing recurrent vulvovaginal candidiasis. Med Mycol J. 2012;53:193.
  20. Weissenbacher T, Witkin SS, Ledger WJ. Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction. Arch Gynecol Obstet. 2009;279:125. doi:10.1007/s00404-008-0681-9
  21. Abakarova PR, Prilepskaya VN, Mezevitinova EA, Bairamova GR, Ivanova EV. Modern possibility of effective treatment of vulvovaginal candidiasis. Akusherstvo i gynekologiya. 2012;7:84-86. (In Russ.).
  22. Prilepskaya BN, Bairamova GR [Vulvovaginal candidiasis. Clinic, diagnostics, principles of therapy]. Moscow: GEOTAR-Media. 2010;80. (In Russ.).
  23. United States Food and Drug Administration Safety Communication: oral fluconazole in pregnancy. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm497656.htm?source=govdelivery&utm_medium=email&utm_source= govdelivery (Accessed on April 26, 2016)
  24. Ivanova II, Stepanyan AV, Dzhobava EM, Dobrokhotova YuE. Experience of the use of fenticonazole in the treatment of vulvovaginal candidiasis. Gynekologiya. 2012;14:1:72-74. (In Russ.).
  25. Stepanyan AV, Ivanova II, Dzhobava EM, Dobrokhotova YuE. New in the treatment of vulvovaginal candidiasis. Voprosy ginekologii, akusherstva i perinatologii. 2012;11:3:86-90. (In Russ.).
  26. Bydanov PV, Aslanov AG, Mysaev ZM, Churganova AA. A modern approach to the treatment of candidal vulvovaginitis with regards antimycotic resistance. Voprosy ginekologii, akusherstva i perinatologii. 2013;12:3:67-71. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.